Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
265,214,861
Total 13F shares
9,526,320
Share change
+5,031,315
Total reported value
$447,661,000
Price per share
$47.03
Number of holders
48
Value change
+$236,962,427
Number of buys
36
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.42%
1,117,317
$33,441,000 30 Jun 2020
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.3%
804,560
$23,067,000 30 Jun 2020
13F
Artisan Partners Limited Partnership
13F
Company
0.19%
494,161
$14,805,000 30 Jun 2020
13F
Artal Group S.A.
13F
Company
0.12%
324,000
$9,697,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0.07%
175,129
$5,242,000 30 Jun 2020
13F
Sio Capital Management, LLC
13F
Company
0.04%
118,409
$3,544,000 30 Jun 2020
13F
FMR LLC
13F
Company
0.02%
52,525
$1,574,000 30 Jun 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.01%
34,966
$1,048,000 30 Jun 2020
13F
S.c.a. Candriam
13F
Individual
0.01%
32,624
$977,000 30 Jun 2020
13F
NORGES BANK
13F
Company
0.01%
30,000
$899,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.01%
23,500
$703,000 30 Jun 2020
13F
Allianz Asset Management GmbH
13F
Company
0.01%
19,910
$596,000 30 Jun 2020
13F
SG Americas Securities, LLC
13F
Company
0.01%
19,421
$582,000 30 Jun 2020
13F
Vident Investment Advisory, LLC
13F
Company
0.01%
15,516
$464,000 30 Jun 2020
13F
ETF MANAGERS GROUP, LLC
13F
Company
0.01%
15,975
$458,000 30 Jun 2020
13F
NEW SILK ROAD INVESTMENT PTE LTD
13F
Company
0%
12,000
$359,000 30 Jun 2020
13F
Invesco Ltd.
13F
Company
0%
7,178
$215,000 30 Jun 2020
13F
ROYAL BANK OF CANADA
13F
Company
0%
1,630
$49,000 30 Jun 2020
13F
Snow Lake Capital (HK) Ltd
13F
Company
0.52%
1,385,975
$41,482 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
0%
147
$4,000 30 Jun 2020
13F

Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2020

As of 30 Sep 2020, NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,526,320 shares. The largest 10 holders included HILLHOUSE CAPITAL ADVISORS, LTD., Avidity Partners Management LP, Snow Lake Capital (HK) Ltd, ADAGE CAPITAL PARTNERS GP, L.L.C., MANUFACTURERS LIFE INSURANCE COMPANY, THE, Artal Group S.A., Artisan Partners Limited Partnership, ORBIMED ADVISORS LLC, SPHERA FUNDS MANAGEMENT LTD., and MORGAN STANLEY. This page lists 48 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
19
Q3 2020 holders
48
Holder diff
29
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.